Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC).
J Bart Rose
No relevant relationships to disclose
Flavio G. Rocha
No relevant relationships to disclose
Bruce S. Lin
No relevant relationships to disclose
Adnan Alseidi
No relevant relationships to disclose
Thomas A. Biehl
No relevant relationships to disclose
Ravi Moonka
No relevant relationships to disclose
John A. Ryan
No relevant relationships to disclose
L. William Traverso
No relevant relationships to disclose
Scott Helton
No relevant relationships to disclose
Vincent J. Picozzi
Stock Ownership - Amgen
Research Funding - Aduro Biotech; Clovis; FibroGen; Immunomedics; Theranostics Health